Origen de la red de primer grado Christopher Yegen.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
IntraBio, Inc.
 IntraBio, Inc. Pharmaceuticals: MajorHealth Technology IntraBio, Inc. is a biopharmaceutical company, which engages in the development of novel treatments for genetic and neurodegenerative diseases. The company was founded by Mallory Factor in 2015 and is headquartered in Tenafly, NJ.
4
| Holding Company | Pharmaceuticals: Major | 4 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Christopher Yegen a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal | |
| Boston College | College/University | Undergraduate Degree | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member | |
California Biomedical Innovation Alliance
 California Biomedical Innovation Alliance BiotechnologyHealth Technology California Biomedical Innovation Alliance provides biomedical advocacy and community services. The private company is based in South San Francisco, CA and has subsidiaries in United States. The CEO of the company is Sara Radcliffe. | Biotechnology | Director/Board Member | |
| ARBUTUS BIOPHARMA CORPORATION | Pharmaceuticals: Major | Director/Board Member | |
| CYTOMX THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| SANGAMO THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Pulmocide Ltd.
 Pulmocide Ltd. Pharmaceuticals: MajorHealth Technology Pulmocide Ltd. provides biopharmaceutical services. It develops inhaled medicines for viral and fungal infections of the respiratory tract. The company was founded by William Garth Rapeport, John Murray, Kazuhiro Ito, and Peter Strong on March 23, 2007 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member |
Estadísticas
Internacional
| Estados Unidos | 8 |
| Reino Unido | 2 |
Sectorial
| Health Technology | 7 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Operativa
| Director/Board Member | 8 |
| Independent Dir/Board Member | 3 |
| Chief Executive Officer | 2 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| James Meyers | 9 |
| Mallory Factor | 1 |
| Elizabeth Factor | 1 |
| Ali Khan | 1 |
- Bolsa de valores
- Insiders
- Christopher Yegen
- Conexiones Empresas
